Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Perampanel in routine clinical use in idiopathic generalized epilepsy: The 12-month GENERAL study
Vicente Villanueva, Javier Montoya, Ascensión Castillo, et al.
Epilepsia (2018) Vol. 59, Iss. 9, pp. 1740-1752
Open Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

Ionotropic Glutamate Receptors in Epilepsy: A Review Focusing on AMPA and NMDA Receptors
Takahisa Hanada
Biomolecules (2020) Vol. 10, Iss. 3, pp. 464-464
Open Access | Times Cited: 199
Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: A systematic review
Bernhard J. Steinhoff, Pavel Klein, Henrik Klitgaard, et al.
Epilepsy & Behavior (2021) Vol. 118, pp. 107939-107939
Open Access | Times Cited: 71
Perampanel as precision therapy in rare genetic epilepsies
Andreea Nissenkorn, Gerhard Kluger, Susanne Schubert‐Bast, et al.
Epilepsia (2023) Vol. 64, Iss. 4, pp. 866-874
Open Access | Times Cited: 26
PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice
Vicente Villanueva, Wendyl D’Souza, Hiroko Goji, et al.
Journal of Neurology (2021) Vol. 269, Iss. 4, pp. 1957-1977
Open Access | Times Cited: 52
The broad-spectrum activity of perampanel: state of the art and future perspective of AMPA antagonism beyond epilepsy
Fabio Perversi, Cinzia Costa, Angelo Labate, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 19
Kainate Receptor Antagonists: Recent Advances and Therapeutic Perspective
Paulina Chałupnik, Ewa Szymańska
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1908-1908
Open Access | Times Cited: 18
Low-Dose Perampanel Rescues Cortical Gamma Dysregulation Associated With Parvalbumin Interneuron GluA2 Upregulation in Epileptic Syngap1+/− Mice
Brennan J. Sullivan, Simon G. Ammanuel, Pavel A. Kipnis, et al.
Biological Psychiatry (2020) Vol. 87, Iss. 9, pp. 829-842
Open Access | Times Cited: 49
Efficacy and tolerability of perampanel as a first add-on therapy with different anti-seizure drugs
Estevo Santamarina, V Bertol, Vanesa Garayoa, et al.
Seizure (2020) Vol. 83, pp. 48-56
Open Access | Times Cited: 43
Exploring the Evidence for Broad-Spectrum Effectiveness of Perampanel: A Systematic Review of Clinical Data in Generalised Seizures
Eugen Trinka, Simona Lattanzi, Kate Carpenter, et al.
CNS Drugs (2021) Vol. 35, Iss. 8, pp. 821-837
Open Access | Times Cited: 33
Effectiveness and safety of perampanel as early add-on treatment in patients with epilepsy and focal seizures in the routine clinical practice: Spain prospective study (PERADON)
Javier Abril Jaramillo, José Carlos Estévez María, Juan Miguel Girón Úbeda, et al.
Epilepsy & Behavior (2019) Vol. 102, pp. 106655-106655
Closed Access | Times Cited: 41
Effectiveness and safety of perampanel monotherapy for focal and generalized tonic‐clonic seizures: Experience from a national multicenter registry
Rafael Toledano, Irene García‐Morales, Beatriz Parejo‐Carbonell, et al.
Epilepsia (2020) Vol. 61, Iss. 6, pp. 1109-1119
Closed Access | Times Cited: 35
Targeting Ionotropic Glutamate Receptors in the Treatment of Epilepsy
Roberta Celli, Francesco Fornai
Current Neuropharmacology (2020) Vol. 19, Iss. 6, pp. 747-765
Open Access | Times Cited: 33
Efficacy and tolerability of perampanel in pediatric patients with Dravet syndrome
Shinsaku Yoshitomi, Yukitoshi Takahashi, Tokito Yamaguchi, et al.
Epilepsy Research (2019) Vol. 154, pp. 34-38
Closed Access | Times Cited: 33
Women With Genetic Epilepsies
Paula Marques, Nagham Kaka, Quratulain Zulfiqar Ali, et al.
Neurology Genetics (2025) Vol. 11, Iss. 1
Open Access
Efficacy and safety of perampanel in genetic generalized epilepsy: a retrospective, single-center study in China
Hua Li, Peiqi Zhang, Xiaoli Dong, et al.
Epilepsy Research (2025) Vol. 215, pp. 107591-107591
Closed Access
Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing Potential
Anna Serafini, Elizabeth E. Gerard, Pierre Genton, et al.
CNS Drugs (2019) Vol. 33, Iss. 3, pp. 195-208
Closed Access | Times Cited: 28
Perampanel effectiveness and tolerability in patients with epilepsy at long-term follow-up
Mariana Fernandes, Filippo Dainese, Francesca Felicia Operto, et al.
Epilepsy & Behavior (2021) Vol. 121, pp. 108069-108069
Closed Access | Times Cited: 22
Efficacy and adverse reactions of perampanel in the treatment of epilepsy in children
Dan Li, Shaoping Huang, Yuqin Wang, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 16
Perampanel for the treatment of patients with myoclonic seizures in clinical practice: Evidence from the PERMIT study
Wendyl D’Souza, Taoufik Alsaadi, Javier Montoya, et al.
Seizure (2022) Vol. 100, pp. 56-66
Open Access | Times Cited: 15
Phase IV PROVE study: Perampanel in real-world clinical care of pediatric patients with epilepsy
Katherine Moretz, James W. Wheless, César Santos, et al.
European Journal of Paediatric Neurology (2024) Vol. 50, pp. 23-30
Closed Access | Times Cited: 3
An Italian multicentre study of perampanel in progressive myoclonus epilepsies
Laura Canafoglia, Giuseppina Barbella, Edoardo Ferlazzo, et al.
Epilepsy Research (2019) Vol. 156, pp. 106191-106191
Closed Access | Times Cited: 23
The efficacy of perampanel as adjunctive therapy in drug-resistant focal epilepsy in a “real world” context: focus on temporal lobe epilepsy
Angelo Pascarella, Luigi Francesco Iannone, Giancarlo Di Gennaro, et al.
Journal of the Neurological Sciences (2020) Vol. 415, pp. 116903-116903
Closed Access | Times Cited: 21
Alternatives to valproate in girls and women of childbearing potential with Idiopathic Generalized Epilepsies: state of the art and guidance for the clinician proposed by the Epilepsy and Gender Commission of the Italian League Against Epilepsy (LICE)
Barbara Mostacci, Federica Ranzato, Loretta Giuliano, et al.
Seizure (2020) Vol. 85, pp. 26-38
Open Access | Times Cited: 21
PROVE: Retrospective, non‐interventional, Phase IV study of perampanel in real‐world clinical care of patients with epilepsy
Robert Wechsler, James W. Wheless, Muhammad Zafar, et al.
Epilepsia Open (2021) Vol. 7, Iss. 2, pp. 293-305
Open Access | Times Cited: 19
Therapeutic drug monitoring of perampanel in children diagnosed with epilepsy: Focus on influencing factors on the plasma concentration‐to‐dose ratio
Yue Li, Na Dong, Yu‐Xin Qin, et al.
Epilepsia Open (2022) Vol. 7, Iss. 4, pp. 737-746
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top